.png){kind=icon}
A
Adriaan A. Voors
H指数:132
被引数:10.3万
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Implications of urinary albumin-to-creatinine ratio for subsequent kidney function decline and kidney-related outcomes in patients hospitalized for worsening heart failure: Insights from the JROADHF-NEXT registry
尿白蛋白肌酐比值对因心力衰竭加重住院患者后续肾功能下降及肾脏相关结局的影响：JROADHF-NEXT登记研究的启示
Effects of natriuresis-guided diuretic therapy in men and women with acute heart failure: insights from PUSH-AHF
钠排泄指导的利尿剂疗法在急性心力衰竭男性和女性中的效果：PUSH-AHF研究的启示
MAGGIC and PREDICT-HF Models in the VICTOR Trial: Do Traditional Risk Scores Still Work in Well-Treated Ambulatory Patients with HFrEF?
MAGGIC和PREDICT-HF模型在VICTOR试验中：传统风险评分在治疗良好的HFrEF门诊患者中是否仍然有效？
Inflammatory and catabolic activity mediate the association of plasma β-hydroxybutyrate and mortality in heart failure
炎症和分解代谢活性介导血浆β-羟基丁酸与心力衰竭患者死亡率的关联
ESC Heart Failure
IF3.7
Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial
维利卡格在HFrEF中的死亡率效益和终身生存获益：VICTOR试验的贝叶斯和精算分析
Circulating Dipeptidyl Peptidase 3 levels, an Antagonist of Angiotensin-(1–7), in Acute Heart Failure: Insights from the PUSH-AHF trial
循环二肽基肽酶3水平，作为血管紧张素-(1–7)的拮抗剂，在急性心力衰竭中的作用：PUSH-AHF试验的见解
Finerenone benefits in patients with cardio-kidney-metabolic syndrome with or without history of cancer: the FINE-HEART pooled analysis
在有无癌症病史的心肾代谢综合征患者中非奈利酮的获益：FINE-HEART合并分析
European Heart Journal
IF35.6
Elevated 5-oxoproline levels and adverse outcomes in heart failure: Association with renal cortical OPLAH loss in a multi-comorbidity model
血5-氧代脯氨酸水平升高与心力衰竭不良预后的关系：在多合并症模型中与肾皮质OPLAH丢失的关联
Redox Biology
IF11.9
Thiazides attenuate the diuretic response to Pecavaptan, a dual vasopressin receptor antagonist, in hospitalized heart failure patients
噻嗪类药物减弱住院心力衰竭患者对双重血管加压素受体拮抗剂Pecavaptan利尿反应
Low-dose digoxin in patients with heart failure with reduced or mildly reduced ejection fraction: a randomized controlled trial
低剂量地高辛在射血分数降低或轻度降低的心力衰竭患者中的应用：一项随机对照试验
Nature Medicine
IF50
Nanoparticle-Mediated Delivery of Adenosine 5′-Monophosphate Enhances 5-Oxoprolinase Activity to Mitigate Oxidative Stress in Heart Failure
纳米颗粒介导的5′-腺苷单磷酸递送增强5-氧脯氨酸酶活性以缓解心力衰竭中的氧化应激
Prevalence and predictors of high inflammatory risk in heart failure subtypes: findings from the global POSEIDON study
心衰亚型中高炎症风险的发生率及其预测因素：全球POSEIDON研究的结果
